Rhelion Life Sciences Corp. ( TRUFF) - Key Metrics
TRUFF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | $0 | $0 | $0 |
| 2026Q4 | $0 | -$0.01 | $0 | $0 |
| 2026Q3 | $0 | $0 | $0 | $0 |
| 2026Q2 | $0 | $0 | $0 | $0 |
| 2026Q1 | $0 | $0 | $0 | $0 |
TRUFF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -2.97 |
| 2026Q4 | 0% | -0.82 |
| 2026Q3 | 0% | -1.69 |
| 2026Q2 | 0% | -3.18 |
| 2026Q1 | 0% | -3.27 |
TRUFF
Price: $0.02
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -1.20
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 7.8 million